Gene · 8564
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mining for Active Molecules in Probiotic Supernatant by Combining Non-Targeted Metabolomics and Immunoregulation Testing. | Metabolites | 2022 | 35050158 | PubTator, text mining | PubMed |
| Immune targets for therapeutic development in depression: towards precision medicine. | Nat Rev Drug Discov | 2022 | 35039676 | PubTator, text mining | PubMed |
| The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors. | Molecules | 2022 | 35011505 | PubTator, text mining | PubMed |
| The impact of bariatric surgery on serum tryptophan-kynurenine pathway metabolites. | Sci Rep | 2022 | 34996930 | PubTator, text mining | PubMed |
| Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease. | J Neuroinflammation | 2022 | 34983592 | PubTator, text mining | PubMed |
| Canine transmissible venereal tumour established in immunodeficient mice reprograms the gene expression profiles associated with a favourable tumour microenvironment to enable cancer malignancy. | BMC Vet Res | 2022 | 34980125 | PubTator, text mining | PubMed |
| iTRAQ-based quantitative proteomics analysis of Sprague-Dawley rats liver reveals perfluorooctanoic acid-induced lipid metabolism and urea cycle dysfunction. | Toxicol Lett | 2022 | 34958885 | PubTator, text mining | PubMed |
| T cell fat catabolism: A novel target for kynurenine? | EBioMedicine | 2022 | 34954657 | PubTator, text mining | PubMed |
| Nephrotoxicity evaluation of 3-monochloropropane-1,2-diol exposure in Sprague-Dawley rats using data-independent acquisition-based quantitative proteomics analysis. | Toxicol Lett | 2022 | 34915118 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? | CNS Neurosci Ther | 2022 | 34862742 | PubTator, text mining | PubMed |
| Neuroinflammation in Huntington's Disease: A Starring Role for Astrocyte and Microglia. | Curr Neuropharmacol | 2022 | 34852742 | PubTator, text mining | PubMed |
| All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease. | Neural Regen Res | 2022 | 34782555 | PubTator, text mining | PubMed |
| Apathy is not associated with a panel of biomarkers in older adults with HIV disease. | J Psychosom Res | 2022 | 34768029 | PubTator, text mining | PubMed |
| Kynurenine pathway in kidney diseases. | Pharmacol Rep | 2022 | 34617264 | PubTator, text mining | PubMed |
| The multifaceted regulation of mitophagy by endogenous metabolites. | Autophagy | 2022 | 34583624 | PubTator, text mining | PubMed |
| Effect of COVID-19 on Household Food Insecurity and Poverty: Evidence from Ghana. | Soc Indic Res | 2022 | 34456451 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression. | Mol Oncol | 2022 | 34379869 | PubTator, text mining | PubMed |
| Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers. | Br J Clin Pharmacol | 2022 | 34327739 | PubTator, text mining | PubMed |
| Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. | Int Rev Immunol | 2022 | 34289794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/papers?page=25